Home > Drug Search >
  • Targets: DOT1 like histone lysine methyltransferase (DOT1L)
  •   > 
Drug Filter
Category:
chemistry (16) biology (1)
Status:
Phase Ⅲ (2) Phase Ⅱ (2) Phase Ⅰ (13)
Clinical Stage:
Pending (3) Active (12) Discontinued (2)
Company:
Cubist Pharmaceuticals (1) Kyowa Hakko Kirin (1) Meiji Seika Pharma (1) Merck Serono (1) Merck Sharp & Dohme (2) Pfizer (1) Roche (1) Sunesis Pharmaceuticals (1) Takeda (1) Teijin Pharma (1) The Medicines Company (1) Vertex (2) Sigma-Tau (1) vTv Therapeutics (1) Epizyme (1) Agios Pharmaceuticals (1) Basilea Pharmaceutica (1) Celgene (3)
Indication:
Acute myeloid Leukemia (AML) (2) Chronic lymphocytic leukemia (CLL) (1) Lymphoma (1) Malignancies (1) Pneumonia (1) Prostate cancer (1) Solid tumours (7) Topical bacterial infection (1) Systemic bacterial infections (1) Hematological cancer (3) Gram-negative bacterial infection (2) Adenosine deaminase deficiency (1) Glioma (1) Bacterial infection (2)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top